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Leptospirosis is a re-emerging zoonosis with broad clinical spectrum and high mortality
in  severe forms. The aim of this study was to analyze clinical manifestations, laboratory
ﬁndings,  epidemiological data, and management in elderly patients with leptospirosis.
Toward  that end, we performed a descriptive analysis of 15 leptospirosis elderly cases (age
60–78  years) treated at the Clinic of Infectious Diseases of University Hospital – Pleven
(1976–2012).  Patients were serologically conﬁrmed by microscopic agglutination test. Twelve
cases  (80%) presented with the severe form of leptospirosis. Co-morbidity (hypertonic dis-
eases, chronic pulmonary diseases, chronic alcohol abuse, and diabetes) was  registered in 13
cases. All cases had fever, oliguria, conjunctival suffusions, hepatosplenomegaly. Jaundice
(14/93%),  hemorrhagic diathesis (13/87%), vomiting (11/73%), abdominal pain (10/67%), myal-
gia (7/47%) and hypotension (7/47%) also were observed. Renal dysfunction was expressed
by  increased blood urea nitrogen (mean 38.1 ± 24.1 mmol/L) and serum creatinine (mean
347.6  ± 179.8 mol/L). Hepatic dysfunction was expressed by increased total serum biliru-
bin  level (mean 274.6 ± 210.7 mol/L) and slightly elevated aminotransferases (ASAT mean
125.8  ± 61.6 IU/L; ALAT mean 131.3 ± 126.5 IU/L). Five cases (33%) had a lethal outcome. In
conclusion,  leptospirosis in elderly patients is associated with severe course and higher risk
for death, and requires prompt intensive treatment.
severe  muscle pain, febrile illness with pulmonary hemor-
© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDLeptospirosis has been recognized as an emerging global pub-
lic  health problem because of its increasing incidence in
both  developing and developed countries. A number of lepto-
spirosis  outbreaks have occurred in the past few years in
various  countries such as Brazil, Nicaragua and India. Some of
these  outbreaks resulted as consequence of natural calamities
such  as cyclone and ﬂoods.1 Leptospirosis is a zoonotic dis-
ease  caused by spirochetes belonging to different pathogenic
species  of the genus Leptospira. Large number of animals acts
as  carriers or vectors. Human infection results from acciden-
tal  contact with carrier animals or environment contaminated
with  leptospires. The primary source of leptospires is the ani-
mal,  from whose renal tubules leptospires are excreted into
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Este é um artigo Open Access sob a licençathe environment with the animal urine. The majority of lep-
tospiral  infections are either sub-clinical or result in very
mild  illness and recover without any complications. How-
ever,  a small proportion develops various complications due
to  involvement of multiple organ systems. In such patients,
the  clinical presentation depends upon the predominant
organs involved and the case fatality rate could be about
40%  or more.  Febrile illness with jaundice, hemorrhages and
nephritis  (known as Weil’s disease), acute febrile illness withpital, 8a “Georgi Cochev” str., 5800 Pleven, Bulgaria.
rhages  in the form of hemoptysis, jaundice with pulmonary
hemorrhages, jaundice with hematuria, meningitis with hem-
orrhages  or febrile illness with cardiac arrhythmias with or
 de CC BY-NC-ND
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ithout hemorrhages are some of the syndromes.2 Because of
he  protean manifestations of leptospirosis it is often misdiag-
osed  and under-reported.3 Delay in diagnosis and treatment
ould  be fatal.4 There are large number of investigations about
he  risk factors for death in leptospirosis and most of them
onﬁrm  age as independent risk factor.5–10 But when reviewing
he  literature we  did not ﬁnd any study focused on leptospi-
osis  in elderly patients.
The  aim of this study was  to analyze clinical man-
festations, laboratory ﬁndings, epidemiological data and
anagement in elderly patients with leptospirosis. Toward
hat  end, we  performed a descriptive analysis of 15 leptospi-
osis  in elderly cases (age ≥60 years) treated at the Clinic of
nfectious  Diseases of University Hospital – Pleven (1976–2012).
atients were serologically screened by microscopic aggluti-
ation  test (MAT)  for leptospirosis (in the National Reference
aboratory at National Center of Infectious and Parasitic Dis-
ases  – Soﬁa). A positive diagnosis was  conﬁrmed if an initial
iter  of ≥100 for MAT  was  observed.
Severity of cases was  complexly assessed as mild, moder-
te  or severe according to the following deﬁnitions11:
Mild form of leptospirosis has been deﬁned at mild to
moderate intoxication, anicteric or mild icterus, without
hemorrhagic diathesis, without involvement of respiratory,
cardiac and central nervous system (CNS), with mild renal
dysfunction without acute renal failure (ARF).
Moderate form of leptospirosis has been deﬁned at markedly
demonstrated intoxication, moderate jaundice, skin hem-
orrhages,  transitory cardiovascular abnormalities without
myocardial dysfunction, ARF improving without dialysis.
Severe  leptospirosis has been deﬁned at severe intoxica-
tion,  marked jaundice with severe hepatic dysfunction,
skin hemorrhages and visceral bleeding, toxic myocarditis,
severe ARF requiring dialysis, common respiratory and CNS-
involvement.
In  this study, out of the 102 leptospirosis cases treated at
he  Clinic of Infectious Diseases of University Hospital–Pleven
rom 1976 through 2012 only 15 (15%) were  aged ≥60 years
anging  from 60 to 78 years; there were  10 male and 5 female
atients,  eight were  urban residents. Epidemiologic analysis
evealed  a history suggestive of leptospirosis in 12 cases (80%)
s  follows: eight patients reported contacts with rats (seven
ndirect  and one direct – rat-biting), wading barefoot in dirty
ater  (in a river, a canal, and after ﬂooding) was  admitted by
hree  patients, ﬁshing by two, falling in a lake by one patient. In
wo cases the disease appeared after grass-mowing and corn-
leaning;  one patient was  a hygiene-staff of the district. In ﬁve
ases more  than one epidemiologic factor were  reported.
The  mean period from clinical onset to hospital admis-
ion  was  4.8 ± 1.66 days (2–7 days). Prior to hospitalization
ve patients had received antibiotics (nephrotoxic gentamycin
n  two of them). Seven patients were admitted directly to
he  Infectious Diseases Clinic – Pleven with primary clinical
iagnosis of leptospirosis and from the remaining eight ﬁve
ere  admitted to the Surgery Clinic with diagnosis of obstruc-
ive  jaundice, one to the Nephrology Clinic with diagnosis of
ephrolythiasis, one to the Internal Medicine ward,  and one to
he Intensive Care Unit (the latter two patients with diagnosis3;1 7(5):592–595  593
of  sepsis). The mean period from onset of clinical manifesta-
tions  to hospital admission was  5 ± 1.7 days (2–7 days).
All cases had fever, oliguria, conjunctival suffusions, hep-
atosplenomegaly. Jaundice (14/93%), hemorrhagic diathesis
(13/87%),  nausea and vomiting (11/73%), abdominal pain
(10/67%),  myalgia (7/47%), hypotension (7/47%) and diarrhea
(4/27%)  also were  observed.
The main laboratory parameters that expressed renal dys-
function  were blood urea nitrogen (mean 38.1 ± 24.1 mmol/L)
and  serum creatinine (mean 347.6 ± 179.8 mol/L). Three cases
(20%)  had ARF with severe electrolytic disorders manifested by
hyperkalaemia and hyponatraemia. Metabolic disorders such
as acidosis were observed in eight 8 (53%) and alkalosis in 2
(13%)  patients.
Hepatic dysfunction was  expressed by increased total
and  direct serum bilirubin level (mean total bilirubin
274.6 ± 210.7 mol/L) besides slightly elevated amino-
transferases (ASAT mean 125.8 ± 61.6 IU/L; ALAT mean
131.3  ± 126.5 IU/L). There was  no apparent evidence of
cholestasis–mean alkaline phosphatase level 365 ± 234 IU/L
and  mean gammaglutamiltransferase 238 ± 164 IU/L. Protein
synthesis  was  affected–mean levels of total protein and
albumins were 58.6 ± 7.81 g/L and 28 ± 6.44 g/L, respectively.
Investigations of blood cells revealed marked leucocytosis
in  14 (93%) with a mean of 18.3 ± 5.6 × 109 L–1, neutrophilia
and thrombocytopenia in seven cases (47%) with a mean of
164  ± 128 × 109 L–1. Fibrinogen elevation was  a typical feature
of  leptospirosis (mean 5.9 ± 1.7 g/L). Laboratory investigations
are  shown in Table 1.
Fourteen  patients (93%) had ARF and one (7%) had prerenal
azotemia. Cardiac involvement with clinical and electrocar-
diographic (ECG) abnormalities was  found in eight patients
(53%).  Four deceased patients had developed myocarditis.
Acute respiratory failure due to lung edema was  observed in
six (40%) patients. Thirteen (87%) had manifested hemorrhagic
diathesis such as skin hemorrhage in nine (60%), hematuria in
nine (60%), epistaxis in three (20%), hematemesis in two (13%),
melena  in 1 (7%). Pancreatic involvement was detected in only
two  (13%) patients.
The  complex assessment of severity, according to the
deﬁnitions mentioned above, revealed that 12 cases (80%)
had  the severe form of leptospirosis and only three cases
(20%)  had the moderate form. Co-morbidity (hypertonic
diseases, chronic pulmonary and heart diseases, chronic alco-
hol  abuse, diabetes, etc.) was  reported in 13 cases (87%)
(Table  2).
Patient management was  initiated immediately after
admission and consisted of intravenous administration of ﬂu-
ids and plasma transfusions. Penicillin (200,000 U/kg per day)
was  administered intravenously to twelve patients during 14
days.  Intravenous ceftriaxone 2.0–4.0 g per day (depending on
diuresis and creatinine levels) was administered when peni-
cillin  had no effect, due to penicillin allergy or in very severe
cases.  Steroid was  used (methylprednisolone 2 mg/kg per day
initial dose), famotidine for gastro-protection, furosemide,
hepato-protective (l-ornitine, ademethionine). Transfusions
of  thrombocyte concentrates were  carried on in cases with
critical  thrombocytopenia and severe multi-site bleeding.
Human albumin was  infused in cases with hypoalbuminemia.
Dialysis was performed in three cases, initiated on the second
594  b r a z j i n f e c t d i s . 2 0 1 3;1  7(5):592–595
Table 1 – Laboratory parameters in elderly patients with leptospirosis.
Parameter Reference value Mean sd Min Max
Hemoglobin (g/L) 120–188 131 20 100 156
Leucocytes (×109 L−1) 4.0–11.0 18.3 5.6 6.1 26.4
Neutrophils (%) 50–80 81 30 67 92
Platelets (cells × 109 L−1) 150–400 164 128 62 437
Urea (mmol/L) 1.7–8.3 38.1 24.1 11.2 98.6
Creatinine (mol/L) 44.2–134 347.6 179.8 99 610
K+ (mmol/L) 3.5–5.6 4.2 1.1 2.7 6.5
Na+ (mmol/L) 130–151 137 5.5 129 148
Total bilirubin (mol/L) 3.4–21 274.5 210.7 35 780
Direct bilirubin (mol/L) 0.8–8.5 219.6 155.2 27 564
ASAT (IU/L) ≤37 126  62 28 625
ALAT (IU/L) ≤40 131 127 11 382
GGT (IU/L) 15–28 238 164 31 508
Alkaline phosphatase (IU/L) 50–260 365 334 70 1431
Lactate dehydrogenase (IU/L) 100–360 1049 877 287 2305
Creatine kinase (IU/L) 80–190 2227 3938 78 8130
Total protein (g/L) 58–80 58.6 7.8 48 72
Albumins (g/L) 35–55 28 6.4 18.5 43.8
Fibrinogen (g/L) 2.0–4.5 5.9 1.7 3.0 8.75
Prothrombin index (%) 80–110 82 20 47 108
Serum amylase (IU/L) 30–300 312.8 309.7 42 1055
Table 2 – Severity, co-morbidity and outcome of leptospirosis in elderly patients.
Age (years) Severity Co-morbidity Outcome
63 Severe Hypertonic disease Survived
60 Moderate Blindness Survived
69 Severe Nephrolythiasis, cholelythiasis Survived
74 Moderate None Survived
68 Moderate Pyelonephritis Survived
71 Severe Diabetes Survived
63 Severe Pneumoﬁbrosis Survived
61 Severe Alcohol  abuse Survived
78  Severe None  Survived
75 Severe Hypertonic disease, ischemic heart disease Survived
63 Severe Stomach ulcer Died
69 Severe Ischemic heart disease Died
71 Severe Myocardial infarction, hypertonic disease Died
chem
berc68 Severe Is
75 Severe Tu
to fourth day because of ineffective conservative treatment of
ARF  and a totally of two to eight séances were  performed.
Despite intensive treatment ﬁve cases died (one had been
dialyzed).  The dynamics of serum bilirubin and creatinine lev-
els in the deceased patients had dramatically increased.
Discussion of the results mentioned above requires ana-
lyzing  global and local information about leptospirosis. The
disease  is endemic in both urban and rural areas worldwide
and  there had been many  outbreaks in the recent past.1 Lepto-
spirosis  is presumed to be the most widespread zoonosis in the
world.  The source of infection in humans is usually either by
direct or indirect contact with urine of an infected animal. The
incidence  is signiﬁcantly higher in warm climate countries
than  in temperate regions. This is mainly due to longer sur-
vival  of leptospires in warm and humid environments.2 In
Bulgaria,  leptospirosis is a reportable disease since 1953, when
a  database and ofﬁcial registration was  initiated. A mean
annual  incidence rate of 0.9–3.1 per 100,000 was  reported dur-
ing  the period 1953–1968 followed by a reduction to 0.1 per
100,000  inhabitants within next ten years. Since 1976, a meanic heart disease Died
ulosis Died
annual  incidence of 0.37 per 100,000 was  reported.11 A total of
102  leptospirosis cases were treated at the Clinic of Infectious
Diseases of University Hospital – Pleven (1976–2012) and only
15  were  aged ≥60 years old. As a result only a small sample
of  elderly patients could be evaluated. Epidemiologic history
suggestive  of leptospirosis was  reported 80% of our cases.
Clinical  leptospirosis can vary from a mild non-speciﬁc
inﬂuenza-like infection to a severe disease, where serious
complications like ARF, myocarditis, pulmonary hemorrhage
and  liver failure are reported.2 Case fatality rates have been
reported  to vary between 3% and 54% as result of the affected
organ/system.5 Only 20% of our cases had a moderate course
and  the remainder had a severe course. Case fatality rate
was  33%. Of the deceased patients two had affection of four
organ/system, another two had affected ﬁve, and one patient
had  affected six organ/system.Renal  involvement is the most serious complication in
leptospirosis and is the commonest cause of death.6 Two
mechanisms have been postulated in the production of lep-
tospiral  renal failure: (1) direct nephrotoxicity brought about
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y various endotoxins or endotoxin-like substances; and (2)
noxic effect due to disturbances in renal circulation. The
ypical  lesion is tubulointerstitial nephritis, characterized by
nterstitial edema and dense focal inﬁltration of predomi-
antly mononuclear cells. Tubular changes are degenerative
n  nature and affect principally the proximal tubules. Intravas-
ular  volume depletion causing vasomotor nephropathy in
his disease has been postulated to occur due to capillary
eakage with associated loss of ﬂuid and protein resulting in
roteinuria.6 In our study 93% of cases had ARF.
Cardiac involvements are a life-threatening complications
f  leptospirosis. Rajiv et al. (1996) have shown that 70% of
he  patients with serologically proven leptospirosis had ECG
bnormalities,  with atrial ﬁbrillation being the commonest
ajor arrhythmia noted.12 The same study reported that 36%
f  the patients had conduction system abnormalities and 30%
ad  T-wave changes. Another case-series has found atrio-
entricular block in 44% of patients with leptospirosis.13 A
lycoprotein fraction of leptospiral cell wall has been incrim-
nated  in the pathogenesis of these rhythm disturbances.
ther reported cardiac abnormalities include myocarditis and
ndocarditis.14 Cardiac involvement with clinical and ECG
bnormalities were  found in 53% of our cases. Four deceased
lderly  patients had myocarditis.
We  consider that co-morbidity had signiﬁcant contribution
o  the severe course observed in elderly patients. All patients
ho  ended up dying had serious co-morbidities that inﬂu-
nced  either directly or indirectly the lethal outcome.
Severe leptospirosis may  carry a high mortality if treat-
ent  is not instituted promptly. Poor prognostic markers in
eptospirosis  reported in various studies include hypoten-
ion,  oliguria and hyperkalemia.7 Other studies have reported
yspnea,  white blood cell count greater than 12,900 mm−3,8
epolarization abnormalities on ECG, alveolar inﬁltrates,9
emoptysis, metabolic acidosis, and thrombocytopenia.15 In
ospitals that have adequate facilities, patients with these
isk  factors should preferably be treated in an Intensive
are Unit.4 The beginning of early pertinent antimicro-
ial therapy within 4–5 days after the onset of illness,
roper supportive therapy and use of dialysis to treat renal
ailure  has reduced the leptospirosis-related mortality.4,15
herefore early predictors of complications are helpful in
etecting  and managing patients with leptospirosis and
lso  to minimize mortality. In our study 53% of cases
ere  not admitted early to the Clinic of Infectious Dis-
ases  due to incorrect primary diagnosis. This is evidence
or  difﬁculty to diagnose especially in elderly patients
hen co-morbidity may  overlap the clinical manifesta-
ions.
13;1 7(5):592–595  595
In conclusion, leptospirosis in elderly patients is associ-
ated  with severe course and higher risk for death and requires
prompt  intensive treatment.
Conﬂict  of  interest
The authors declare no conﬂict of interest.
 e  f  e  r  e  n  c  e  s
1. Agampodi S, Peacock SJ, Thevanesam V. The potential
emergence of leptospirosis in Sri Lanka. Lancet Infect Dis.
2009;9:524–6.
2. Levett PN. Leptospirosis. Clin Microbiol Rev. 2001;14:296–326.
3. Vijayachari P, Sugunan AP, Shriram AN. Leptospirosis: an
emerging  global public health problem. J Biosci.
2008;33:557–656.
4. Kobayashi Y. Human leptospirosis: management and
prognosis. J Postgrad Med. 2005;51:201–4.
5.  Ko AI, Galvao Reis M, Ribeiro Dourado CM, Johnson Jr WD,
Riley  LW. Urban epidemic of severe leptospirosis in Brazil.
Lancet.  1999;354:820–5.
6. Orpilla-Bautista ICL, Panaligan MM.  Predictors of mortality
among patients with leptospirosis admitted at the JRRMMC.
Phil  J Microbiol Infect Dis. 2002;3:145–9.
7.  Panaphut T, Domrongkitchaiporn S, Thinkamrop B. Prognostic
factors of death in leptospirosis: a prospective cohort study in
Khon Kaen, Thailand. Int J Infect Dis. 2002;6:52–9.
8. Katz AR, Ansdell VE, Efﬂer PV, Middleton CR, Sasaki DM.
Assessment of the clinical presentation and treatment of 353
cases  of laboratory-conﬁrmed leptospirosis in Hawaii,
1974–1998. Clin Infect Dis. 2001;33:1834–41.
9.  Dupont H, Dupont-Perdrizet D, Perie JL, Zehner-Hansen S,
Jarrige  B, Daijardin JB. Leptospirosis: prognostic factors
associated with mortality. Clin Infect Dis. 1997;25:720–4.
0. Dassanayake D, Wimalaratna H, Nandadewa D, Nugaliyadda
A,  Ratnatunga C, Agampodi S. Predictors of the development
of  myocarditis or acute renal failure in patients with
leptospirosis: an observational study. BMC Infect Dis.
2012;12:4, http://dx.doi.org/10.1186/1471-2334-12-4.
1. Gancheva G. Complex studies on leptospirosis. Bulgaria:
Medical University – Pleven; 2006 (PhD dissertation).
2. Rajiv C, Manjuran RJ, Sudhayakumar N, Haneef M.
Cardiovascular involvement in leptospirosis. Indian Heart J.
1996;48:691–4.
3.  Trivedi SV, Bhattacharya A, Amichandwala K, Jakkamsetti V.
Evaluation  of cardiovascular status in severe leptospirosis. J
Assoc  Phys India. 2003;51:951–3.
4.  Shah K, Amonkar GP, Kamat RN, Deshpande JR. Cardiac
ﬁndings in leptospirosis. J Clin Pathol. 2010;63:119–23.
5. Spichler A, Vilac¸a  P, Athanazio D, et al. Predictors of lethality
in  severe leptospirosis in urban Brazil. Am J Trop Med Hyg.
2008;79:911–4.
